Chiron Real Estate cuts dividend as portfolio transition accelerates
The real estate investment trust reduced its monthly common stock cash dividend by approximately 36% to $0.16 a share [12][22][39].
Chiron Real Estate (XRN), a healthcare real estate investment trust, withdrew its full-year earnings guidance as it shifted its asset base toward luxury senior housing.
The company is undergoing a strategic portfolio transition, marked by the divestment of inpatient rehabilitation facilities and a pivot toward higher-end residential care. This shift led management to scrap its previous Core FFO per share guidance range of $4.30 to $4.45 to focus on capital redeployment.
Financial results for the first quarter ended March 31, 2026, reflected the impact of these dispositions. Pro forma rental revenue decreased to $33.9 million from a historical $38.0 million. Pro forma net loss attributable to common stockholders widened to $3.4 million, compared to a historical net loss of $0.7 million for the same period.
Operational momentum slowed during the quarter. Same-property cash net operating income growth fell to 3.2% year-over-year, down from 5.4% in the previous quarter. Portfolio leased occupancy also declined to 95.4% as of March 31, from 96.0% at the end of 2025.
To fund its new direction, the company signed purchase agreements for three luxury seniors housing communities in Alexandria, Virginia, and North Bethesda, Maryland, for an aggregate price of approximately $425 million.
These acquisitions follow the sale of seven inpatient rehabilitation facilities for $217.0 million, which resulted in an estimated gain on sale of $70.7 million. Chiron retained a 15% ownership interest in the resulting joint venture from that transaction.
To support its liquidity needs, the company entered into a $100 million delayed-draw, convertible preferred equity facility with affiliates of Maewyn Capital Partners for new 6.00% Series C Convertible Preferred Stock.